Vildan N. Civelek
Boston Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vildan N. Civelek.
Diabetes | 1997
Vildan N. Civelek; Jude T. Deeney; Glenn E. Fusonie; Barbara E. Corkey; Keith Tornheim
To determine whether oscillations in glycolysis could underlie the oscillations in O2 consumption observed in intact islets, we evaluated the capacity of an islet extract to exhibit spontaneous oscillations in glycolysis. When a cell-free extract obtained from ∼1,000 islets was supplied with glucose and glycolytic cofactors, oscillations in NADH fluorescence were obtained. After this demonstration of spontaneous oscillations in islet extracts, we bathed permeabilized clonal β-cells in the more plentiful spontaneously oscillating glycolytic muscle extract that generates pulses of α-glycerophosphate and pyruvate and induces oscillations in free Ca2+ and the ATP/ADP ratio. This preparation was used to investigate whether changes in Ca2+ and possibly α-glycerophosphate or pyruvate supply could underlie observed oscillations in O2 consumption and explain coordination between cytosolic and mitochondrial metabolism. We found that oscillations of O2 consumption and Ca2+ of a similar period were induced. Removal of medium Ca2+ with EGTA did not prevent the oscillations in O2 consumption nor were they greatly affected by the substantial rise in medium Ca2+ on treatment with thapsigargin to inhibit sequestration into the endoplasmic reticulum. The O2 oscillations were also not eliminated by the addition of relatively high concentrations of pyruvate or α-glycerophosphate. However, they were lost on addition of fructose-2,6-P2 at concentrations that prevent oscillations of glycolysis and the ATP/ADP ratio. Addition of a high concentration of ADP increased O2 consumption and also prevented O2 oscillations. These results suggest that the changes in respiration reflected in the O2 oscillations occur in response to the oscillations in the ATP/ADP ratio or ADP concentration and that this parameter is a primary regulator of O2 consumption in the pancreatic β-cell.
Biochemical Journal | 2003
Barbara A Cunningham; Ann-Marie T. Richard; Joseph S. Dillon; Jennifer T Daley; Vildan N. Civelek; J T Deeney; Gordon C. Yaney; Barbara E. Corkey; Keith Tornheim
Glucose-induced insulin secretion from isolated, perifused rat islets is pulsatile with a period of about 5-10 min, similar to the insulin oscillations that are seen in healthy humans but which are impaired in Type II diabetes. We evaluated the pattern of enhancement by the potent incretin, glucagon-like peptide 1 (GLP-1). GLP-1 increased the amplitude of pulses and the magnitude of insulin secretion from the perifused islets, without affecting the average time interval between pulses. Forskolin and the phosphodiesterase inhibitor isobutylmethylxanthine had the same effect, suggesting that the effect was due to elevated cAMP levels. The possibility that cAMP might enhance the amplitude of pulses by reducing phosphofructo-2-kinase (PFK-2) activity was eliminated when the liver isoform of PFK-2 was shown to be absent from beta-cells. The possibility that cAMP enhanced pulsatile secretion, at least in part, by stimulating lipolysis was supported by the observations that added oleate had a similar effect on secretion, and that the incretin effect of GLP-1 was inhibited by the lipase inhibitor orlistat. These data show that the physiological incretin GLP-1 preserves and enhances normal pulsatile insulin secretion, which may be essential in proposed therapeutic uses of GLP-1 or its analogues.
Biochemical Journal | 1996
Vildan N. Civelek; Jude T. Deeney; Nicholas J Shalosky; Keith Tornheim; Richard G. Hansford; Marc Prentki; Barbara E. Corkey
American Journal of Physiology-endocrinology and Metabolism | 2001
Frank Caserta; Tamara Tchkonia; Vildan N. Civelek; Marc Prentki; Nicholas F. Brown; J. Denis McGarry; R. Armour Forse; Barbara E. Corkey; James A. Hamilton; James L. Kirkland
Journal of Biological Chemistry | 1994
James A. Hamilton; Vildan N. Civelek; Frits Kamp; Keith Tornheim; B E Corkey
Biochemical Journal | 1996
Vildan N. Civelek; Jude T. Deeney; Kari Kubik; Vera Schultz; Keith Tornheim; Barbara E. Corkey
Diabetes | 2001
Gordon C. Yaney; Vildan N. Civelek; Ann-Marie T. Richard; Joseph S. Dillon; Jude T. Deeney; James A. Hamilton; Helen M. Korchak; Keith Tornheim; Barbara E. Corkey; Aubrey E. Boyd
Journal of Biological Chemistry | 1994
Lisa Juntti-Berggren; Vildan N. Civelek; Per-Olof Berggren; Vera Schultz; B E Corkey; Keith Tornheim
Archive | 2013
L. Kirkland; J. Denis McGarry; R. Armour; B E Corkey; James A. Hamilton; Tamara Tchkonia; Vildan N. Civelek; Marc Prentki; Nicholas F. Brown
Diabetes | 1997
Vildan N. Civelek; Jude T. Deeney; Glenn E. Fusonie; Barbara E. Corkey; Keith Tornheim